BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20422882)

  • 21. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile.
    QuirĂ³s-Tejeira RE; Rivera CA; Ziba TT; Mehta N; Smith CW; Butte NF
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):228-36. PubMed ID: 17255837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
    Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
    Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body mass index and waist circumference in non-alcoholic fatty liver disease.
    Rocha R; Cotrim HP; Carvalho FM; Siqueira AC; Braga H; Freitas LA
    J Hum Nutr Diet; 2005 Oct; 18(5):365-70. PubMed ID: 16150132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
    Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
    Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
    Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.
    Uchil D; Pipalia D; Chawla M; Patel R; Maniar S; Narayani ; Juneja A
    J Assoc Physicians India; 2009 Mar; 57():201-4. PubMed ID: 19588647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty liver in adolescents on the U.S.-Mexico border.
    Sharp DB; Santos LA; Cruz ML
    J Am Acad Nurse Pract; 2009 Apr; 21(4):225-30. PubMed ID: 19366381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vryonidou A; Ioannidis D; Kosma L; Katsoulis K; Papavassiliou E; Tzavara I
    Hum Reprod; 2010 Jan; 25(1):212-20. PubMed ID: 19887498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.
    Lee YS; Kek BL; Poh LK; Saw SM; Loke KY
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):172-8. PubMed ID: 18664869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of Yiqi Sanju Formula on non-alcoholic fatty liver disease: a randomized controlled trial].
    Lou SY; Liu Y; Ma YY; Chen HY; Chen WH; Ying J; He YM; Wang WJ
    Zhong Xi Yi Jie He Xue Bao; 2008 Aug; 6(8):793-8. PubMed ID: 18664346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease.
    Tapan S; Dogru T; Kara M; Ercin CN; Kilciler G; Genc H; Sertoglu E; Acikel C; Kilic S; Karslioglu Y; Kurt I; Erbil MK
    Scand J Clin Lab Invest; 2010 Oct; 70(6):399-403. PubMed ID: 20604719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity.
    Civera M; Urios A; Garcia-Torres ML; Ortega J; Martinez-Valls J; Cassinello N; del Olmo JA; Ferrandez A; Rodrigo JM; Montoliu C
    Diabetes Metab Res Rev; 2010 Mar; 26(3):187-92. PubMed ID: 20222158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.
    Bugianesi E; Pagotto U; Manini R; Vanni E; Gastaldelli A; de Iasio R; Gentilcore E; Natale S; Cassader M; Rizzetto M; Pasquali R; Marchesini G
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3498-504. PubMed ID: 15797948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.
    Aktas B; Yilmaz Y; Eren F; Yonal O; Kurt R; Alahdab YO; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E
    Metabolism; 2011 Apr; 60(4):544-9. PubMed ID: 20580037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.